Compare BHST & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHST | MLSS |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3M | 42.6M |
| IPO Year | 2017 | 1996 |
| Metric | BHST | MLSS |
|---|---|---|
| Price | $1.49 | $0.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $10.50 | $1.25 |
| AVG Volume (30 Days) | 31.0K | ★ 62.0K |
| Earning Date | 11-12-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,973,982.00 |
| Revenue This Year | $8.59 | $11.14 |
| Revenue Next Year | $29.48 | $13.80 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.99 |
| 52 Week Low | $1.42 | $0.22 |
| 52 Week High | $12.80 | $0.60 |
| Indicator | BHST | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 28.91 | N/A |
| Support Level | N/A | N/A |
| Resistance Level | $1.77 | N/A |
| Average True Range (ATR) | 0.10 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 15.73 | 0.00 |
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.